Vimarsana.com

Latest Breaking News On - Susquehanna fundamental investments - Page 3 : comparemela.com

Thermon Group Holdings, Inc. (NYSE:THR) SVP Mark John Roberts Sells 2,910 Shares

Thermon Group Holdings, Inc. (NYSE:THR – Get Free Report) SVP Mark John Roberts sold 2,910 shares of Thermon Group stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $33.35, for a total value of $97,048.50. Following the transaction, the senior vice president now owns 50,920 shares of […]

Entrypoint
British-columbia
Canada
United-states
America
Roth-mkm
Mark-john-roberts
Thermon-group-price-performance
Hedge-funds-weigh-in-on-thermon-group
Thermon-group-holdings-inc
Susquehanna-fundamental-investments
News-ratings-for-thermon-group-daily

Short Interest in Canaan Inc. (NASDAQ:CAN) Rises By 7.7%

Canaan Inc. (NASDAQ:CAN – Get Free Report) was the recipient of a significant increase in short interest in May. As of May 15th, there was short interest totalling 28,650,000 shares, an increase of 7.7% from the April 30th total of 26,590,000 shares. Based on an average daily volume of 13,290,000 shares, the short-interest ratio is […]

Ivyrock-asset-management-hk-ltd
Headlands-technologies
Canaan-inc
Susquehanna-fundamental-investments
Quadrature-capital-ltd
Sg-americas-securities
Nasdaq
Get-free-report
Capital-ltd
Fundamental-investments
Rock-asset-management

Insider Selling: Allogene Therapeutics, Inc. (NASDAQ:ALLO) Director Sells 11,200 Shares of Stock

Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) Director Franz B. Humer sold 11,200 shares of the company’s stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $2.34, for a total value of $26,208.00. Following the completion of the sale, the director now owns 255,253 […]

Canada
Franzb-humer
Piper-sandler
Canada-life-assurance
Pricet-rowe-associates-inc
Allogene-therapeutics-company-profile
Nasdaq
Allogene-therapeutics-inc
Susquehanna-fundamental-investments
Jpmorgan-chase-co
Securities-exchange-commission
Headlands-technologies

Rackspace Technology, Inc. (NASDAQ:RXT) Receives Average Rating of "Hold" from Brokerages

Shares of Rackspace Technology, Inc. (NASDAQ:RXT – Get Free Report) have received a consensus rating of “Hold” from the eight research firms that are presently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and two have issued a buy recommendation […]

Canada
Raymond-james
Raymond-james-associates
Tower-research-capital
Rackspace-technology-inc
Analyst-recommendations-for-rackspace-technology
Multicloud-services
Rackspace-technology-stock-performance
Rackspace-technology
Royal-bank
Susquehanna-fundamental-investments
Insider-transactions-at-rackspace-technology

CytomX Therapeutics (NASDAQ:CTMX) Upgraded at Piper Sandler

Piper Sandler upgraded shares of CytomX Therapeutics (NASDAQ:CTMX – Free Report) from a neutral rating to an overweight rating in a report published on Tuesday morning, MarketBeat.com reports. Piper Sandler currently has $3.50 price objective on the biotechnology company’s stock, up from their prior price objective of $2.25. A number of other research firms have […]

Piper-sandler
Seana-mccarthy
Jpmorgan-chase-co
Congress-park-capital
Alphamark-advisors
Jefferies-financial-group
Acadian-asset-management
Sg-americas-securities
Susquehanna-fundamental-investments
Cytomx-therapeutics-inc
Cytomx-therapeutics-company-profile
Securities-exchange-commission

vimarsana © 2020. All Rights Reserved.